Back
Logitech International SA Vs. Blueprint Medicines Industry Stock Comparison
Buy
56
LOGI
Logitech International SA
Last Price:
$92.66
Seasonality Move:
-3.22%
Sell
50
BPMC
Blueprint Medicines
Last Price:
$128.39
Seasonality Move:
6.28%
Buy
56
Logitech International SA (LOGI)
is a Buy
Is Logitech International SA a Buy, Sell or Hold?
-
The current Logitech International SA [LOGI] share price is $92.69. The Score for LOGI is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
LOGI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Blueprint Medicines (BPMC)
is a Sell
Is Blueprint Medicines a Buy, Sell or Hold?
-
The current Blueprint Medicines [BPMC] share price is $128.35. The Score for BPMC is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
BPMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LOGI Stock Price Chart
What is Logitech International SA's stock price today?
-
The Logitech International SA share price today is $92.69Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LOGI is experiencing slight buying pressure.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $128.35Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing slight buying pressure.
LOGI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.06 | Buy |
Relative Strength Index (14 RSI): | 68.89 | Buy |
Chaikin Money Flow: | 5402 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (83.83 - 89.65) | Buy |
Bollinger Bands (100): | (77.23 - 96.25) | Buy |
BPMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.65 | Buy |
Relative Strength Index (14 RSI): | 74.59 | Buy |
Chaikin Money Flow: | 675123 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (119 - 133.06) | Buy |
Bollinger Bands (100): | (84.56 - 117) | Buy |
LOGI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 90.24 | Buy |
20-day SMA: | 87.55 | Buy |
50-day SMA: | 84.28 | Buy |
200-day SMA: | 85.93 | Buy |
8-day EMA: | 90.39 | Buy |
20-day EMA: | 88.1 | Buy |
50-day EMA: | 85.87 | Buy |
200-day EMA: | 85.96 | Buy |
BPMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 128.23 | Buy |
20-day SMA: | 128.14 | Buy |
50-day SMA: | 111.57 | Buy |
200-day SMA: | 97.6 | Buy |
8-day EMA: | 128.16 | Buy |
20-day EMA: | 125.23 | Buy |
50-day EMA: | 115.07 | Buy |
200-day EMA: | 100.77 | Buy |
Logitech International SA Earnings Growth & LOGI Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.14 per share, an increase this year of $0.86 per share, and a decrease next year of $0.25 per share.
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.33 per share, an increase this year of $0.60 per share, and an increase next year of $1.50 per share.
Logitech International SA Technical Analysis
Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Blueprint Medicines Technical Analysis
Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |